1. Home
  2. ODD vs BLFS Comparison

ODD vs BLFS Comparison

Compare ODD & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ODD

ODDITY Tech Ltd.

HOLD

Current Price

$12.67

Market Cap

845.9M

Sector

N/A

ML Signal

HOLD

Logo BioLife Solutions Inc.

BLFS

BioLife Solutions Inc.

HOLD

Current Price

$20.68

Market Cap

923.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODD
BLFS
Founded
2018
1987
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
845.9M
923.5M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
ODD
BLFS
Price
$12.67
$20.68
Analyst Decision
Hold
Strong Buy
Analyst Count
11
1
Target Price
$41.00
$32.00
AVG Volume (30 Days)
1.3M
328.6K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.27
EPS
N/A
0.02
Revenue
N/A
$96,214,000.00
Revenue This Year
N/A
$19.73
Revenue Next Year
$22.92
$17.82
P/E Ratio
$16.73
$1,049.50
Revenue Growth
N/A
16.97
52 Week Low
$10.80
$17.86
52 Week High
$79.18
$29.57

Technical Indicators

Market Signals
Indicator
ODD
BLFS
Relative Strength Index (RSI) 34.25 43.77
Support Level $12.53 $19.71
Resistance Level $15.73 $20.47
Average True Range (ATR) 1.02 0.95
MACD -0.24 -0.15
Stochastic Oscillator 7.93 17.85

Price Performance

Historical Comparison
ODD
BLFS

About ODD ODDITY Tech Ltd.

ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: